Iron Gate Global Advisors’s PDS Biotechnology PDSB Stock Holding History

Iron Gate Global Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.4K	Buy	75,022 +6	+0%	+$5	﹤0.01%	104
2025 Q4	$57.7K	Hold	75,016	–	–	0.01%	99
2025 Q3	$76.5K	Buy	+75,016	New	+$88.2K	0.01%	110
2025 Q2	–	Sell	-75,016	Closed	-$89.3K	–	94
2025 Q1	$89.3K	Buy	+75,016	New	+$107K	0.01%	90
2024 Q4	–	Sell	-75,016	Closed	-$287K	–	95
2024 Q3	$287K	Hold	75,016	–	–	0.04%	69
2024 Q2	$220K	Hold	75,016	–	–	0.04%	90
2024 Q1	$295K	Hold	75,016	–	–	0.05%	78
2023 Q4	$373K	Hold	75,016	–	–	0.07%	65
2023 Q3	$377K	Hold	75,016	–	–	0.08%	57
2023 Q2	$377K	Hold	75,016	–	–	0.08%	61
2023 Q1	$461K	Hold	75,016	–	–	0.11%	51
2022 Q4	$990K	Hold	75,016	–	–	0.27%	36
2022 Q3	$223K	Buy	+75,016	New	+$318K	0.06%	75
2021 Q3	–	Sell	-25,239	Closed	-$316K	–	123
2021 Q2	$316K	Buy	+25,239	New	+$197K	0.09%	80
2021 Q1	–	Sell	-13,192	Closed	-$28K	–	101
2020 Q4	$28K	Hold	13,192	–	–	0.01%	92
2020 Q3	$31K	Hold	13,192	–	–	0.01%	97
2020 Q2	$27K	Buy	+13,192	New	+$14.7K	0.01%	86
2019 Q4	–	Sell	-14,641	Closed	-$49K	–	81
2019 Q3	$49K	Buy	+14,641	New	+$85.2K	0.03%	70

Other funds holding PDSB

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Iron Gate Global Advisors's PDSB Position: Q1 2026 in Review

Iron Gate Global Advisors increased its PDS Biotechnology (PDSB) stake by 0.01% in Q1 2026, buying an estimated $5 and bringing the position to 75,022 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #104.

Iron Gate Global Advisors first reported a position in PDSB in Q3 2019 and has held it in 18 quarters since. The position peaked at $990K in Q4 2022. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

Iron Gate Global Advisors held 75,022 shares of PDS Biotechnology worth $45.4K as of Q1 2026.
Iron Gate Global Advisors bought 6 PDS Biotechnology shares in Q1 2026, an estimated $5.
PDS Biotechnology made up ﹤0.01% of Iron Gate Global Advisors's portfolio in Q1 2026, its #104 holding.
Iron Gate Global Advisors first reported a position in PDS Biotechnology in Q3 2019 and has held it in 18 quarters since.
Iron Gate Global Advisors's PDS Biotechnology position peaked at $990K in Q4 2022.
41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Iron Gate Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.